Standard BioTools Analyst Ratings
Standard BioTools Analyst Ratings
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $4.00. The current price Standard BioTools (LAB) is trading at is $2.28, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | Keybanc | → $4 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | KeyBanc | →$4 | 開始承保 | →超重 |
What is the target price for Standard BioTools (LAB)?
標準生物工具(LAB)的目標價格是多少？
The latest price target for Standard BioTools (NASDAQ: LAB) was reported by Keybanc on July 12, 2023. The analyst firm set a price target for $4.00 expecting LAB to rise to within 12 months (a possible 75.44% upside). 1 analyst firms have reported ratings in the last year.
標準生物工具(納斯達克：LAB)的最新目標價是由Keybanc於2023年7月12日報道的。這家分析公司將目標價定為4美元，預計LAB將在12個月內上漲(可能上漲75.44%)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Standard BioTools (LAB)?
標準生物工具(LAB)的最新分析師評級是多少？
The latest analyst rating for Standard BioTools (NASDAQ: LAB) was provided by Keybanc, and Standard BioTools initiated their overweight rating.
標準生物工具公司(納斯達克代碼：LAB)的最新分析師評級是由Keybanc提供的，標準生物工具公司啟動了其增持評級。
When is the next analyst rating going to be posted or updated for Standard BioTools (LAB)?
標準生物工具(LAB)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Standard BioTools, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Standard BioTools was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與標準生物工具的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。標準生物工具的上一次評級是在2023年7月12日提交的，所以你應該預計下一次評級將在2024年7月12日左右提供。
Is the Analyst Rating Standard BioTools (LAB) correct?
分析師對標準生物工具(LAB)的評級正確嗎？
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $4.00. The current price Standard BioTools (LAB) is trading at is $2.28, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的標準生物工具(LAB)評級是以0.00美元至4.00美元的目標價啟動的。目前標準生物工具(LAB)的交易價格為2.28美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
